Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.

Clinical trial NCT03069170 · UNKNOWN

Trial details

NCT number: NCT03069170
Sponsor: Stem Cells Arabia
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2016-07-01
Primary completion: 2020-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.